
    
      N-Acetylcysteine (NAC) is known to be relatively safe and beneficial in peritoneal dialysis
      patient at a dose of 1200 mg per day. Patients will be randomly assigned to NAC and control
      group and prescribed according to the protocol. At 2 and 6 month, Peritoneal equilibrium test
      (PET) will be performed with blood sampling.
    
  